IMAC Holdings, Inc. (IMAC): Price and Financial Metrics
GET POWR RATINGS... FREE!
IMAC Stock Summary
- IMAC has a market capitalization of $26,732,330 -- more than approximately only 4.98% of US stocks.
- IMAC's went public 3.13 years ago, making it older than merely 9.92% of listed US stocks we're tracking.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for IMAC comes in at -69.11% -- higher than that of only 6.09% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to IMAC Holdings Inc, a group of peers worth examining would be EVH, HLIO, HMTV, MEG, and MNSB.
- IMAC's SEC filings can be seen here. And to visit IMAC Holdings Inc's official web site, go to www.imacregeneration.com.
IMAC Valuation Summary
- IMAC's price/sales ratio is 2.9; this is 74.45% lower than that of the median Healthcare stock.
- IMAC's EV/EBIT ratio has moved up 3.4 over the prior 31 months.
- IMAC's price/earnings ratio has moved up 1.1 over the prior 31 months.
Below are key valuation metrics over time for IMAC.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| IMAC | 2021-08-31 | 2.9 | 1.5 | -7.6 | -7.4 |
| IMAC | 2021-08-30 | 2.8 | 1.5 | -7.3 | -7.0 |
| IMAC | 2021-08-27 | 2.8 | 1.5 | -7.2 | -6.9 |
| IMAC | 2021-08-26 | 2.8 | 1.5 | -7.2 | -6.9 |
| IMAC | 2021-08-25 | 2.7 | 1.4 | -7.0 | -6.8 |
| IMAC | 2021-08-24 | 2.8 | 1.4 | -7.1 | -6.9 |
IMAC Price Target
For more insight on analysts targets of IMAC, see our IMAC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $3.63 | Average Broker Recommendation | 1.75 (Moderate Buy) |
IMAC Stock Price Chart Interactive Chart >
IMAC Price/Volume Stats
| Current price | $1.03 | 52-week high | $2.75 |
| Prev. close | $1.05 | 52-week low | $0.75 |
| Day low | $1.03 | Volume | 1,843 |
| Day high | $1.03 | Avg. volume | 916,234 |
| 50-day MA | $0.92 | Dividend yield | N/A |
| 200-day MA | $1.20 | Market Cap | 27.28M |
IMAC Holdings, Inc. (IMAC) Company Bio
IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. Its services include medical treatments, regenerative medicine, physical medicine, physical therapy, spinal decompression and chiropractic manipulation. The company was founded by Matthew C. Wallis, Jason William Brame and Jeffrey S. Ervin in August 2000 and is headquartered in Brentwood, TN.
Latest IMAC News From Around the Web
Below are the latest news stories about IMAC Holdings Inc that investors may wish to consider to help them evaluate IMAC as an investment opportunity.
IMAC Holdings, Inc. Announces Completion of Second Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s DiseaseBRENTWOOD, Tenn., Feb. 16, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has completed the second cohort of its Phase 1 clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinson’s disease. The second cohort consists of five patients with bradykinesia due to Parkinson’s disease receiving an intravenous infusion of a medium concentra |
Ben Lerner to join IMAC as COOIMAC Holdings < |
IMAC Holdings, Inc., Announces Dr. Ben Lerner as Chief Operating OfficerDr. Lerner, a New York Times best-selling author and holistic health and business expert, brings healthcare growth experience to IMAC executive team. BRENTWOOD, Tenn., Feb. 09, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative and rehabilitative orthopedic treatments without the use of surgery or opioids, announces the addition of healthcare veteran Dr. Ben Lerner to the posit |
IMAC Holdings, Inc. Enters 2022 with Improved Balance SheetCompany reduces significant debt in 2021 BRENTWOOD, Tenn., Jan. 19, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, has announced the repayment of three loans representing more than 95% of its debt in accordance with scheduled debt service over the past 10 months. “We worked diligently to reduce our |
IMAC Holdings to launch BACK.co app to provide mobile queue registrationIMAC Holdings (IMAC) to launch BACK.co app for the The Back Space pilot program to provide mobile queue registration and serves to helping consumers develop a personalized, affordable |
IMAC Price Returns
| 1-mo | 31.65% |
| 3-mo | -2.83% |
| 6-mo | -21.37% |
| 1-year | -44.32% |
| 3-year | -74.57% |
| 5-year | N/A |
| YTD | -9.65% |
| 2021 | -25.49% |
| 2020 | 2.00% |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...